Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
The Institute Of Blood Transfusion Cams is currently navigating 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 2 distinct examiners and 2 distinct art units, which requires managing different examination tracks simultaneously. This distribution suggests that the institute is pursuing multiple innovations that fall under different jurisdictions within the Biotechnology & Pharmaceuticals field.
MCKNIGHT, CIARA A is identified as the busiest examiner with 1 busiest examiner pending action. Given that there are 2 pending office actions in total, the workload is distributed among 2 distinct examiners, necessitating a strategy that addresses the specific requirements of different officials. To successfully manage the current filings, the applicant must be prepared for potentially different examination styles and technical focuses. The involvement of 2 distinct art units indicates a diversified approach to the institute's current patent prosecution efforts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCKNIGHT, CIARA A | 1 | 61.5% | +40.3% |
| UNDERDAHL, THANE E | 1 | 58.8% | +50.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18344501 | EVALUATION METHOD OF PATHOGEN INACTIVATION EFFECT | MCKNIGHT, CIARA A | — |
| 18085597 | Blood pathogen inactivation method | UNDERDAHL, THANE E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18344501 | EVALUATION METHOD OF PATHOGEN INACTIVATION EFFECT | MCKNIGHT, CIARA A | — |
| 18085597 | Blood pathogen inactivation method | UNDERDAHL, THANE E | — |
| Art Unit | Apps |
|---|---|
| 1656 | 1 |
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18344501 | EVALUATION METHOD OF PATHOGEN INACTIVATION EFFECT | MCKNIGHT, CIARA A | 1656 | §101§102 | Final Rejection | — | Pending | Jun 29, 2023 |
| 18085597 | Blood pathogen inactivation method | UNDERDAHL, THANE E | 1699 | §103§112 | Final Rejection | — | Pending | Dec 21, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialInstitute Of Blood Transfusion Cams has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Ciara A Mcknight has the most, with 1 of Institute Of Blood Transfusion Cams's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
